↓ Skip to main content

Too Fast or Not Too Fast: The FDA's Approval of Merck's HPV Vaccine Gardasil

Overview of attention for article published in The Journal of Law, Medicine & Ethics, January 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#33 of 1,177)
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
4 news outlets
twitter
45 tweeters
facebook
8 Facebook pages
googleplus
1 Google+ user
video
1 video uploader

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
96 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Too Fast or Not Too Fast: The FDA's Approval of Merck's HPV Vaccine Gardasil
Published in
The Journal of Law, Medicine & Ethics, January 2021
DOI 10.1111/j.1748-720x.2012.00698.x
Pubmed ID
Authors

Lucija Tomljenovic, Christopher A. Shaw

Abstract

There are not many public health issues where views are as extremely polarized as those concerning vaccines, and Merck's HPV vaccine Gardasil is a case in point. Ever since gaining the FDA's approval in 2006, Merck has been heavily criticized for their overly aggressive marketing strategies and lobbying campaigns aimed at promoting Gardasil as a mandatory vaccine. Subsequently, questions have been raised as to whether it was appropriate for vaccine manufacturers to partake in public health policies when their conflicts of interests are so obvious. Some of their advertising campaign slogans, such as "cervical cancer kills x women per year" and "your daughter could become one less life affected by cervical cancer," seemed more designed to promote fear rather than evidence-based decision making about the potential benefits of the vaccine. Although, conflicts of interests do not necessarily mean that the product itself is faulty, marketing claims should be carefully examined against factual science data. Currently Gardasil vaccination is strongly recommended by the U.S. and other health authorities while public concerns about safety and efficacy of the vaccine appear to be increasing. This discrepancy leads to some important questions that need to be resolved. The current review examines key issues of this debate in light of currently available research evidence.

Twitter Demographics

The data shown below were collected from the profiles of 45 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 96 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
United States 1 1%
Turkey 1 1%
Canada 1 1%
Unknown 92 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 22 23%
Student > Master 15 16%
Researcher 13 14%
Student > Ph. D. Student 11 11%
Student > Doctoral Student 8 8%
Other 13 14%
Unknown 14 15%
Readers by discipline Count As %
Medicine and Dentistry 27 28%
Agricultural and Biological Sciences 13 14%
Nursing and Health Professions 11 11%
Social Sciences 9 9%
Biochemistry, Genetics and Molecular Biology 6 6%
Other 12 13%
Unknown 18 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 66. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 November 2022.
All research outputs
#537,935
of 22,559,910 outputs
Outputs from The Journal of Law, Medicine & Ethics
#33
of 1,177 outputs
Outputs of similar age
#19,001
of 493,752 outputs
Outputs of similar age from The Journal of Law, Medicine & Ethics
#4
of 73 outputs
Altmetric has tracked 22,559,910 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,177 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.4. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 493,752 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 73 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.